CTOs on the Move

Don Cotner Farms

www.cotnerfarms.com

 
Don Cotner Farms is a Danville, PA-based company in the Manufacturing sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Novelis

Novelis is the world leader in rolled aluminum products, delivering unique solutions for the most demanding global applications, such as beverage cans, automobiles, architecture and consumer electronics. Our unique material advantage, customer-focused innovation and unparalleled commitment to sustainability define the Novelis brand.

Waterous Company

Waterous Company is a South Saint Paul, MN-based company in the Manufacturing sector.

Old Trapper Smoked Products

Old Trapper Smoked Products is a Forest Grove, OR-based company in the Manufacturing sector.

South-East Tool Co

South-East Tool Co is a Dayton, OH-based company in the Manufacturing sector.

enVVeno

enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company`s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe™. CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the SAVVE U.S. pivotal study and the company is currently waiting for regulatory approval to begin the TAVVE first-in-human trial for enVVe.